Prostate Cancer Trial, Recruiting NCT06497283 Sponsor: Gangnam Severance Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06497283
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are scheduled to have surgery under general anesthesia
  • You are between 20 and 60 years old
  • You are considered generally healthy or have only mild health conditions (as assessed by your anesthesiologist)
  • Your ideal body weight is between 50 and 80 kg (roughly 110 to 176 lbs)

Who may not be able to join:

  • You have a hearing impairment or disability
  • You have taken opioid painkillers or sedative medications within the past week
  • You have a dependency on alcohol or drugs
  • You have a known allergy or sensitivity to the medications remimazolam or remifentanil
  • You have an irregular heartbeat, heart disease, heart failure, or low blood volume
  • You have liver failure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0220194601

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gangnam Severance Hospital
Registry
ClinicalTrials.gov
Start date
12 July 2024
Est. completion
1 February 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Intraoperative remifentanil dose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov